Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698867 · ClinicalTrials.gov registry record
A Clinical Investigation of the Discovery™ Elbow System
A clinical trial, sponsored by Biomet Orthopedics.
- Completed
- Registry status
- 118
- Enrollment target
NCT00698867: Completed study, sponsored by Biomet Orthopedics.
NCT00698867 is a clinical trial that has completed, run by Biomet Orthopedics. The registered enrollment target is 118 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00698867 has completed, sponsored by Biomet Orthopedics.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
Study Summary
The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of function will determine long-term clinical outcome while durability will be measured by the absence of revisions.
Primary Outcome
This is a patient reported outcome measure that indicates the patient's pain as measured on the ASES form. The maximum pain score is 50 and the minimum score is 0. A higher pain score indicates the subject is in more pain. A lower pain score indicates less pain.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2002-06 |
| Est. Completion | 2016-07 |
What the finished NCT00698867 record still lists
NCT00698867 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00698867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00698867 about?
NCT00698867 is a clinical study titled "A Clinical Investigation of the Discovery™ Elbow System". The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of function will determine long-term clinical outcome while durability will be measured by the absence of revisions.
What is the current status of trial NCT00698867?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2002-06. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT00698867?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia